Clinical Trials Directory

Trials / Completed

CompletedNCT04221880

Erector Spinae Plane Block Versus Perioperative Intravenous Lidocaine for Thoracotomy

Erector Spinae Plane Block Versus Perioperative Intravenous Lidocaine for Postoperative Pain Control in Patients Undergoing Thoracotomy: A Prospective, Randomized, Double-blind Controlled Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Ataturk University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Thoracotomy surgery is the most painful of all surgical procedures. Inadequate postoperative pain control in these patients may cause serious morbidity related to pulmonary, cardiovascular and emotional systems. Erector Spinae Plane Block (ESPB) was first described in 2016 and, it is frequently used for postoperative analgesia in thoracic surgery. Intravenous lidocaine exhibit analgesic activity through both the peripheral and central nervous system. Intravenous lidocaine has been shown to reduce postoperative pain intensity and accelerate postoperative recovery in many surgeries. The investigators aimed to compare the effect of lidocaine infusion and erector spinae plane block on postoperative opioid consumption and pain scores.

Conditions

Interventions

TypeNameDescription
DRUGBupivacaine Hcl 0.25% InjUltrasound-guided erector spinae plane block with 20 ml %0.25 bupivacaine
DRUGSaline Solution for BlockUltrasound-guided erector spinae plane block with 20 ml saline
DRUGSaline Solution intravenouslySame volume saline solution bolus and infusion as Group Lidocaine
DRUGLidocaine1.5 mg / kg lidocaine iv. bolus and, 1.5mg / kg / h lidocaine iv. infusion

Timeline

Start date
2021-09-29
Primary completion
2022-03-01
Completion
2022-03-15
First posted
2020-01-09
Last updated
2022-05-16

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04221880. Inclusion in this directory is not an endorsement.